Begin main content

daclatasvir

Last Updated: January 6, 2016
Result type: Reports
Project Number: SF0467-000
Product Line: Common Drug Review

Generic Name: daclatasvir

Brand Name: Daklinza

Manufacturer: Bristol Myers Squibb Canada Inc.

Indications: Hepatitis C, chronic

Submission Type: Request For Advice

Project Status: Active

Date Recommendation Issued: May 19, 2016

Recommendation Type: Reimburse with clinical criteria and/or conditions

Tags

hepatitis c, hepatitis